U.S. federal trademark · Serial No. 87328186
Blood-based testing to determine the aggressiveness of a patient's cancer and prognosis on treatments including cytotoxic agents, targeted therapies and immunotherapy
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.